These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3042470)

  • 1. A comparative evaluation of timolol maleate and pilocarpine in the treatment of chronic open angle glaucoma.
    Dallas NL; Sponsel WE; Hobley AJ
    Eye (Lond); 1988; 2 ( Pt 3)():243-9. PubMed ID: 3042470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The progress of the visual field in chronic simple glaucoma and ocular hypertension treated topically with pilocarpine or with timolol.
    Crick RP; Newson RB; Shipley MJ; Blackmore H; Bulpitt CJ
    Eye (Lond); 1990; 4 ( Pt 4)():563-71. PubMed ID: 2226985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Timolol and functional perimetric prognosis of primary open-angle glaucoma].
    Demailly P; Aubrier G; Abadie P
    J Fr Ophtalmol; 1985; 8(5):383-8. PubMed ID: 4093536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lang lecture 1986. The enigma of primary open-angle glaucoma.
    Smith RJ
    Trans Ophthalmol Soc U K (1962); 1986; 105 ( Pt 6)():618-33. PubMed ID: 3310339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The additional pressure-lowering effect in patients with glaucoma of pilocarpine 2 per cent, adrenaline 1 per cent, or guanethidine 3 per cent with adrenaline 0.5 per cent and timolol 0.25 per cent: a double-blind cross-over study.
    O'Connor MA; Mooney DJ
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 6)():588-92. PubMed ID: 6385355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamics of visual function in glaucoma patients treated with various antiglaucoma preparations].
    Zhaboedov GD; Slavnova AV; Fedirko PA
    Oftalmol Zh; 1989; (2):69-72. PubMed ID: 2755662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of a double-blind study comparing the effects of timolol and pilocarpine in 110 patients with chronic open-angle glaucoma].
    Plane C; Sole P; Hamard H; Vidal R; Ourgaud AG; Chagnon A
    J Fr Ophtalmol; 1978 Dec; 1(12):733-8. PubMed ID: 155098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
    Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A
    Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of the effectiveness and safety of levobunolol and timolol in ocular hypertension and chronic open-angle glaucoma].
    Freyler H; Novack GD; Menapace R; Skorpik C; Mordaunt J; Batoosingh AL
    Klin Monbl Augenheilkd; 1988 Sep; 193(3):257-60. PubMed ID: 3070134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of local hypotensive therapy on ocular hemodynamics in patients with primary open-angle glaucoma].
    Bakshinskiĭ PP
    Vestn Oftalmol; 1999; 115(1):8-10. PubMed ID: 10207311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%.
    Sihota R; Agarwal HC; Rajashekar YL
    Indian J Ophthalmol; 1996 Jun; 44(2):87-9. PubMed ID: 8916595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trial of Pilogel HS made by Alcon].
    Vymazal M; Válková Z; Poláchová M; Dokonalová E; Dragounová H; Jezdinský J
    Cesk Oftalmol; 1990 Jul; 46(4):301-6. PubMed ID: 2205400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term study of chronic glaucoma treated with beta blockers (timolol)].
    Steinbach PD; Gruia DG
    Klin Monbl Augenheilkd; 1987 Jun; 190(6):534-8. PubMed ID: 3114544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary open-angle glaucoma. Effects of an eyedrop combining timolol and pilocarpine on the ocular pressure].
    Leroy C; Collignon-Brach J
    J Fr Ophtalmol; 1990; 13(1-2):29-32. PubMed ID: 2212504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.
    Kass MA
    Trans Am Ophthalmol Soc; 1989; 87():598-618. PubMed ID: 2562546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.